| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 66547-09-9 | Ansamitocin P-3 | C32H43ClN2O9 |
| 66548-22-9 | 1,2-Bis(tert-butyldimethylsilyloxy)ethane | C14H34O2Si2 |
| 66548-69-4 | 3-Methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolo[4,3-b]pyridazine | C13H9F3N4 |
| 66553-17-1 | 2-Ethyl-1,3-butanediol | C6H14O2 |
| 66556-91-0 | (3alpha,4alpha)-3-Hydroxykaur-16-en-18-oic acid | C20H30O3 |
| 66560-05-2 | N-[(10-Oxido-9,10-dihydro-9-oxa-10-phosphaphenanthrene)methyl]-6-phenyl-1,3,5-triazine-2,4-diamine | C22H18N5O2P |
| 66563-68-6 | 1H-Perfluorododecane | C12HF25 |
| 66564-14-5 | Cinitapride | C21H30N4O4 |
| 66564-89-4 | Ethenyldiethoxymethylsilane polymer with 1,3-diisocyanatomethylbenzene alpha-hydro-omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)] 2,2'-oxybis[ethanethiol] alpha,alpha',alpha''-1,2,3-propanetriyltris[omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)]] and 2-propen-1-ol | |
| 66568-97-6 | 7-Hydroxy-5,4'-dimethoxyflavanone | C17H16O5 |
| 66572-55-2 | 6-Methoxynicotinic acid | C7H7NO3 |
| 66572-56-3 | 2-Bromoisonicotinic acid | C6H4BrNO2 |
| 66574-84-3 | N-Acetyl-2-fluoro-DL-phenylalanine | C11H12FNO3 |
| 66575-29-9 | Forskolin | C22H34O7 |
| 66576-71-4 | Isopropyl 2-methylbutanoate | C8H16O2 |
| 66584-31-4 | 3-Methoxy-5-methylphenylamine | C8H11NO |
| 66584-72-3 | Ansamitocin P 3 | C32H43ClN2O9 |
| 66592-87-8 | Cefadroxil | C16H17N3O5S |
| 66592-89-0 | 4-Isothioureidobutyronitrile hydrochloride | C5H9N3S.HCl |
| 66597-68-0 | 4-Chloro-2-(2-hydroxyethyl)-5-[(2-hydroxyethyl)methylamino]-3(2H)-pyridazinone | C9H14ClN3O3 |
| 66600-05-3 | 2-Chloro-5-phenylpyridine | C11H8ClN |
| 66604-31-7 | Dodecyldimethylchlorosilane | C14H31ClSi |
| 66605-57-0 | N-Boc-L-Phenylalaninol | C14H21NO3 |
| 66605-58-1 | [(1S)-1-(Hydroxymethyl)-2-[4-(phenylmethoxy)phenyl]ethyl]carbamic acid 1,1-dimethylethyl ester | C21H27NO4 |
| 66607-27-0 | 3-Iodoindazole | C7H5IN2 |
| 66611-27-6 | Butanedioic acid, compd. with 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (1:2) | 2(C14H16N2O).C4H6O4 |
| 66611-37-8 | N-[2-Hydroxy-3-(1-piperidinyl)propoxy]-3-pyridinecarboximidamide dihydrochloride | C14H22N4O2.2(HCl) |
| 66612-29-1 | N-(4-Aminobutyl)-N-ethylisoluminol | C14H20N4O2 |
| 66616-69-1 | Ethyl 5-phenyl-1H-indole-2-carboxylate | C17H15NO2 |
| 66617-58-1 | N-tert-Butoxycarbonyl-L-phenylalanine benzyl ester | C21H25NO4 |
| 66621-73-6 | 2-Pyrimidineacetic acid | C6H6N2O2 |
| 66622-47-7 | alpha-Methyl-3-(2-methylpropyl)benzeneacetic acid | C13H18O2 |
| 66625-78-3 | Jojoba wax | |
| 66627-72-3 | 1-(2-Methoxyphenyl)-4,4-dimethyl-1-(1H-1,2,4-triazol-1-yl)-1-penten-3-one | C16H19N3O2 |
| 66630-68-0 | 6,7-Dihydrodipyrido[1,2-a:2',1'-c]pyrazinediium dibromide mixt. with Cutrine Plus | |
| 66634-44-4 | Corynanthine hydrochloride | C21H26N2O3.HCl |
| 66634-82-0 | 2-Propen-1-ol, polymer with 2,2'-[1,2-ethanediylbis(oxy)]bis[ethanethiol], ethenylethoxydimethylsilane, alpha-hydro-omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)], 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and alpha,alpha',alpha''-1,2,3-propanetriyltris[omega-hydroxypoly[oxy(methyl-1,2-ethanediyl)]] | |
| 66635-92-5 | (S)-Ketorolac | C15H13NO3 |
| 66635-93-6 | (R)-Ketorolac | C15H13NO3 |
| 66638-22-0 | O-Acetyl-L-serine hydrochloride | C5H9NO4.HCl |
| 66640-86-6 | Biotin hydrazide | C10H18N4O2S |
| 66640-93-5 | L-alpha-Difluoromethylornithine | C6H12F2N2O2 |
| 66641-26-7 | N-Acetyl-5-L-isoleucine-angiotensinogen (tetradecapeptide renin substrate) | C87H125N21O21 |
| 66642-36-2 | (2S)-N-(4-Methyl-2-oxo-2H-1-benzopyran-7-yl)-5-oxo-2-pyrrolidinecarboxamide | C15H14N2O4 |
| 66644-80-2 | 2,3-Dimethoxy-5-sulphamoylbenzoic acid | C9H11NO6S |
| 66644-81-3 | Veralipride | C17H25N3O5S |
| 66648-43-9 | N-trans-Feruloyltyramine | C18H19NO4 |
| 66648-44-0 | N-Feruloyloctopamine | C18H19NO5 |
| 66648-45-1 | N-p-Coumaroyloctopamine | C17H17NO4 |
| 66648-50-8 | Ethyl caffeate | C11H12O4 |